| 000 | 01437 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513123348.0 | ||
| 264 | 0 | _c19970826 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0002-9440 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNomura, A | |
| 245 | 0 | 0 |
_aRole of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. _h[electronic resource] |
| 260 |
_bThe American journal of pathology _cAug 1997 |
||
| 300 |
_a539-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtoxicity |
| 650 | 0 | 4 |
_aComplement C3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aComplement Inactivator Proteins _xpharmacology |
| 650 | 0 | 4 |
_aComplement Membrane Attack Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aElapid Venoms _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Tubules _xdrug effects |
| 650 | 0 | 4 |
_aNephrosis _xchemically induced |
| 650 | 0 | 4 |
_aPuromycin Aminonucleoside _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aMorita, Y | |
| 700 | 1 | _aMaruyama, S | |
| 700 | 1 | _aHotta, N | |
| 700 | 1 | _aNadai, M | |
| 700 | 1 | _aWang, L | |
| 700 | 1 | _aHasegawa, T | |
| 700 | 1 | _aMatsuo, S | |
| 773 | 0 |
_tThe American journal of pathology _gvol. 151 _gno. 2 _gp. 539-47 |
|
| 999 |
_c9229899 _d9229899 |
||